SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-17-042222
Filing Date
2017-08-11
Accepted
2017-08-11 08:00:18
Documents
2
Period of Report
2017-08-11
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K v472730_8k.htm 8-K 19937
2 EXHIBIT 99.1 v472730_ex99-1.htm EX-99.1 33716
  Complete submission text file 0001144204-17-042222.txt   54952
Mailing Address 445 PARK AVENUE 9TH FLOOR NEW YORK NY 10022
Business Address 445 PARK AVENUE 9TH FLOOR NEW YORK NY 10022 212-829-5546
OPIANT PHARMACEUTICALS, INC. (Filer) CIK: 0001385508 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 000-55330 | Film No.: 171023000
SIC: 1000 Metal Mining